|
Analysis: Covid's "new normal" has set in but there are issues in coping with it. |
mike kraft |
Group Post |
09/11/23 |
|
Analysis: COVID-19 digital contact tracing worked — heed the lessons for future pandemics |
mike kraft |
Group Post |
07/03/23 |
|
Analysis: Desperate airlines hope vaccine mandates will lure back passengers |
mike kraft |
Group Post |
10/08/21 |
|
ANALYSIS: Detailed discussion of ways to speed coronavirus testing. |
mike kraft |
Group Post |
08/14/20 |
|
ANALYSIS: Dr. Debora Birx says number of US coronavirus deaths could have been "decreased substantially" |
mike kraft |
Group Post |
03/28/21 |
|
Analysis: Evaluating the latest uptick in covid-19 cases from the new varient |
mike kraft |
Group Post |
08/15/23 |
|
Analysis: Evolution is on omicron subvariants’ side |
mike kraft |
Group Post |
06/28/22 |
|
Analysis: Experts question reliance on monkeypox vaccine with little data, short supply |
mike kraft |
Group Post |
08/23/22 |
|
Analysis: Experts say it's 'meaningless' to compare case counts, positivity rates from the current Omicron BA.5 subvariant wave to earlier spikes |
mike kraft |
Group Post |
07/12/22 |
|
Analysis: Face masks keep kids safe from Covid-19 and keep schools open. There’s no evidence they harm kids developmentally. |
mike kraft |
Group Post |
02/14/22 |
|
Analysis: Failures in achieving COVID-19 vaccine equity |
mike kraft |
Group Post |
05/05/23 |
|
Analysis: Falling demand for COVID boosters makes price hikes more likely |
mike kraft |
Group Post |
10/21/22 |
|
ANALYSIS: Five reasons why COVID herd immunity is probably impossible |
mike kraft |
Group Post |
03/19/21 |
|
Analysis: Following COVID-19 precautions was closely linked to traditional values except in the U.S.--study |
mike kraft |
Group Post |
04/12/23 |
|
Analysis: Global COVID cases expected to increase in coming months, but at a slower pace -report |
mike kraft |
Group Post |
10/25/22 |
|
ANALYSIS: Global COVID-19 cases surpass 200 mln as Delta variant spreads |
mike kraft |
Group Post |
08/04/21 |
|
Analysis: Governments want COVID vaccine developers to aim higher in developing new and better shots |
mike kraft |
Group Post |
03/31/22 |
|
Analysis: Has the US forgotten about Covid? |
mike kraft |
Group Post |
08/19/22 |
|
Analysis: How America Lost the COVID-19 War |
mike kraft |
Group Post |
04/24/23 |
|
ANALYSIS: How America’fumbled its response to the coronavirus |
mike kraft |
Group Post |
07/20/20 |
|
Analysis: How climate change is increasing immune health problems and how to counter it |
mike kraft |
Group Post |
04/05/24 |
|
Analysis: How COVAX failed on its promise to vaccinate the world |
mike kraft |
Group Post |
10/08/21 |
|
Analysis: How Covid data gaps in states allowed Delta to proliferate |
mike kraft |
Group Post |
09/02/21 |
|
ANALYSIS: How Europe Went Wrong in Its Vaccine Rollout |
mike kraft |
Group Post |
03/20/21 |
|
Analysis: How long immunity might last after a COVID infection |
mike kraft |
Group Post |
01/23/24 |
|
ANALYSIS: How Melbourne, Australia, eradicated Covid-19 |
mike kraft |
Group Post |
12/05/20 |
|
Analysis: How Omicron highlights fading hope of herd immunity from COVID |
mike kraft |
Group Post |
01/20/22 |
|
ANALYSIS: How richer countries got their vaccine supplies first |
mike kraft |
Group Post |
04/01/21 |
|
ANALYSIS: How the Pandemic now ends and the difficult path |
mike kraft |
Group Post |
08/13/21 |
|
ANALYSIS: How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead |
mike kraft |
Group Post |
01/30/21 |
|
Analysis: How the U.S. CDC’s communication failures during Covid tarnished the agency |
mike kraft |
Group Post |
10/03/22 |
|
ANALYSIS: How wellness influencers are fueling the anti-vaccine movement |
mike kraft |
Group Post |
09/14/21 |
|
Analysis: Human rights that protect the enviiornment --some legal facets |
mike kraft |
Group Post |
03/22/21 |
|
Analysis: Impact of Misinformation, and Mistrust on Use of Ivermectin and Hydroxychloroquine for COVID-19 |
mike kraft |
Group Post |
10/02/23 |
|
Analysis: in red states, vast majority of seniors have been vaccinated, despite GOP vaccine resistance |
mike kraft |
Group Post |
10/10/22 |
|
ANALYSIS: In Search for the virus, WHO let China take charge |
mike kraft |
Group Post |
11/02/20 |
|
ANALYSIS: India, the world’s largest vaccine producer struggles to overcome its latest COVID-19 surge—and that’s everyone’s problem. |
mike kraft |
Group Post |
04/26/21 |
|
ANALYSIS: Inside the Fall of the CDC- in depth |
mike kraft |
Group Post |
10/16/20 |
|
ANALYSIS: Inside Trump’s pressure campaign on federal scientists over a covid-19 treatment |
mike kraft |
Group Post |
08/31/20 |
|
Analysis: Is WHO's aim to vaccinate 70% of world by June still realistic? |
mike kraft |
Group Post |
02/28/22 |
|
Analysis: Lancet COVID Panel report blasts governments’ and WHO covid response |
mike kraft |
Group Post |
09/14/22 |
|
Analysis: Lessons from past outbreaks can stop new epidemics in their tracks |
mike kraft |
Group Post |
11/04/22 |
|
Analysis: Long Covid has contributed to thousands of U.S. deaths --CDC |
mike kraft |
Group Post |
12/14/22 |
|
ANALYSIS: Looking at Biden's pragmatic approach to coronavirus rules |
mike kraft |
Group Post |
07/08/21 |
|
Analysis: Medium COVID Could Be the Most Dangerous COVID |
mike kraft |
Group Post |
10/11/22 |
|
Analysis: Minimizing COVID-19 disruption and ensuring the supply of essential health products |
mike kraft |
Group Post |
12/20/21 |
|
ANALYSIS: Most vaccine clinical trials fail to report data on participants’ ethnicity or race |
mike kraft |
Group Post |
02/19/21 |
|
ANALYSIS: New COVID Vaccines Need Absurd Amounts of Material and Labor |
mike kraft |
Group Post |
01/05/21 |
|
Analysis: New variant XBB.1.5 is ‘most transmissible’ yet, could fuel covid wave |
mike kraft |
Group Post |
01/09/23 |
|
Analysis: Obesity and COVID-19 mortality are correlated-study |
mike kraft |
Group Post |
04/13/23 |
Recent Comments